Back
Autolus Therapeutics Plc Stock Predictions
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
59
AUTL
Autolus Therapeutics Plc
Last Price:
$1.92
Seasonality Move:
-20.08%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atAutolus Therapeutics Plc Stock Forecast
-
Is Autolus Therapeutics Plc Stock Undervalued?The current Autolus Therapeutics Plc [AUTL] share price is $1.95. The Score for AUTL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AUTL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Autolus Therapeutics Plc Stock Go Up Next Year?
Data Unavailable
Autolus Therapeutics Plc Stock Rating
Data Unavailable
Autolus Therapeutics Plc Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
autolus.com
52-Week Data
52-Week High:
2.70
52-Week Low:
1.11
Prediction Charts
Market Cap:
519M
Price in USD:
1.95
Volume:
2M
Beta:
1.91
Technical Analysis
SMA50:
1.52
SMA100:
1.55
SMA200:
1.72
52-Wk Change:
-22.62%
Stock Predictions
-
Is Autolus Therapeutics Plc stock public?Yes, Autolus Therapeutics Plc is a publicly traded company.
-
What is the Autolus Therapeutics Plc stock quote today?The Autolus Therapeutics Plc stock price is 1.95 USD today.
-
How to buy Autolus Therapeutics Plc stock online?You can buy Autolus Therapeutics Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-15 | 1.59 | 1.62 | 1.68 | 1.59 |
| Dec-16 | 1.62 | 1.60 | 1.66 | 1.58 |
| Dec-17 | 1.61 | 1.56 | 1.64 | 1.56 |
| Dec-18 | 1.59 | 1.57 | 1.62 | 1.56 |
| Dec-19 | 1.59 | 1.63 | 1.67 | 1.59 |
| Dec-22 | 1.62 | 1.73 | 1.79 | 1.61 |
| Dec-24 | 1.65 | 1.68 | 1.69 | 1.63 |
| Dec-26 | 1.68 | 1.67 | 1.68 | 1.63 |
| Dec-29 | 1.70 | 1.87 | 1.94 | 1.70 |
| Dec-30 | 1.88 | 1.97 | 1.99 | 1.87 |
| Dec-31 | 1.98 | 1.99 | 2.05 | 1.92 |
| Jan-5 | 1.88 | 1.86 | 1.90 | 1.77 |
| Jan-6 | 1.87 | 2.00 | 2.03 | 1.83 |
| Jan-7 | 2.00 | 1.95 | 2.07 | 1.94 |
Autolus Therapeutics Plc Earnings
Data Unavailable
Autolus Therapeutics Plc Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.21 per share.
* Autolus Therapeutics Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.